End-of-day quote
Other stock markets
|
||
- EGP | - |
May. 19 | Ibnsina Pharma Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Mar. 03 | Ibnsina Pharma Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Business Summary
Sales per Business
EGP in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Medical and Semi-medical Products
100.0
%
| 22,264 | 100.0 % | 33,949 | 100.0 % | +52.48% |
Sales per region
EGP in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Egypt
100.0
%
| 22,264 | 100.0 % | 33,949 | 100.0 % | +52.48% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 00-12-17 | |
Chief Executive Officer | - | 00-12-17 | |
Momen Gomaa
DFI | Director of Finance/CFO | - | - |
Chief Tech/Sci/R&D Officer | - | - | |
Director/Board Member | - | - | |
Investor Relations Contact | - | 17-10-31 | |
Corporate Officer/Principal | - | - | |
Sales & Marketing | - | - | |
Ahmed Refaat
HRO | Human Resources Officer | - | 12-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 00-12-17 | |
Chief Executive Officer | - | 00-12-17 | |
Director/Board Member | - | - | |
Director/Board Member | - | - | |
Director/Board Member | - | - | |
Director/Board Member | - | - | |
Chairman | - | - | |
Director/Board Member | - | - | |
Director/Board Member | - | - | |
Director/Board Member | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 1,008,000,000 | 618,896,741 ( 61.40 %) | 0 | 61.40 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
-37.88% | 13.99B | |
-32.35% | 10.67B | |
-20.52% | 6.75B | |
+12.54% | 6.29B | |
-11.51% | 5.88B | |
+75.00% | 4.96B | |
-2.63% | 4.61B | |
-9.20% | 3.74B | |
-19.40% | 3.16B |
- Stock Market
- Equities
- ISPH Stock
- Stock
- Company Ibnsina Pharma Co